세계의 의료용 일렉트로닉스 시장 : 예측(2024-2029년)

The medical electronics market is anticipated to expand at a CAGR of 5.64% over the forecast period to reach US$87.895 billion by 2029, increasing from estimated value of US$66.804 billion in 2024.

Medical electronic comprises of devices which are used in healthcare facilities, clinical service points and institutes in the overall patient monitoring. Preferences for such devices is witnessing a significant growth fueled by the growing volume of minimal invasive surgical procedures. Furthermore, technological innovations in medical devices, and efforts in improving overall patient monitoring, followed by favorable government schemes and investments to bolster medical electronics and components manufacturing are anticipated to drive the market expansion.

Market Drivers.

• Favorable regulations and government initiatives are propelling the market growth.

Furthermore, various healthcare regulations that have been put in place by governing authorities are driving the medical electronics market concerning the need for research and development. Moreover, developments on the technological side will lead to exponential growth in the medical device market. Additionally, there's an increasing focus on integrating advanced technology within the devices, and this move stems from the increasing convenience of accurate and efficient diagnosis as well as treatment.

The provisions to subsidize medical expenditures in emerging economies further make them a lucrative market for medical electronics. For instance, according to the April 2023 PIB press release, the Union Cabinet approved the "National Medical Device Policy 2023" which aimed to make India a global leader in medical devices & innovations and to also increase its market share from 1.5% to 10-12% in the next 25 years.

• A growing number of minimally invasive surgical procedures has stimulated the market demand.

Minimally invasive surgeries enable surgeons to have access to a patient's organs through a small cut or incision thereby reducing the time of wound healing. Such surgeries are linked to lesser pain and complications. To further enhance the recovery timing and limit the operating time, such surgeries require advanced medical devices and surgical robots. The growing prevalence of such surgical procedures in major nations has provided major growth prospects. For instance, according to the American Society of Plastic Surgeons, in 2022, cosmetic minimally invasive surgeries stood at 8,735,591 which represented a significant increase of 73% over the number of procedures conducted in 2019. Furthermore, as per the same source, Non-Invasive fat reduction surgeries witnessed 77% growth in the same year.

Additionally, the prevalence of brain tumors is witnessing significant growth in various nations which is further expected to drive the demand for medical electronic devices required to keep a constant check on patient's brain health. For instance, according to the Brain Tumor Charity's data, over 12,000 people in the United Kingdom are diagnosed with a brain tumor every year, and the same source stated the brain along with other central nervous system tumors is the 9th most common cancer detected in the UK and accounts 3% of new cancer cases.

• Growing healthcare spending has propelled the market growth

Medical electronics constitute an integral part of the medical products conducted for various diagnostic purposes such as during CT & MRI scans, X-rays, and ultrasound. The growing healthcare has paved the way for future market growth. According to the Canada Institute of Health Information, in 2022, the country's healthcare spending reached $332 billion or approximately $8,563 per Canadian, which represented an 8.5% increase over 2020's spending. Moreover, according to the Eurostat, in 2021, the general government expenditure on healthcare in the EU accounted for 8.1% of the overall GDP.

Additionally, the booming old age population and chronic disease prevalence are further anticipated to create a positive drive in the medical electronics market demand. According to the World Bank, in 2022, the population aged 65 years and above accounted for 10% of the global population which signified a 2% increase over 2015.

• North America is anticipated to account for a considerable market share.

North America is expected to show significant growth and will account for a significant portion of the overall market fueled by the growing investments in healthcare infrastructure by the major regional economies namely the United States and Canada. For instance, according to the "2024 Edition American Hospital Association", the total number of hospitals in the United States stood at 6,120 in 2022, which represented an increase of 27 units in comparison to 2020. Additionally, as per the November 2023 press release by the Government of Newfoundland and Labrador, the province has completed the construction of Western Memorial Regional Hospital which will provide varied medical & diagnostic services inclusive of cancer diagnostics.

Key Development

• In May 2024: GE Healthcare launched a new Radiation Therapy (RT) computed tomography (CT) solution at the "European Society For Therapeutic Radiology and Oncology (ESTRO: 2024 Congress". The new product aims to address the challenge faced during oncology care by increasing image accuracy and providing the required personalization and diligence for diagnosis & treatment procedures.
• In July 2023: Abbott Laboratories received FDA approval for its dual; chamber leadless pacemaker system "AVEIR(TM) DR" which would treat people with abnormal or slow heart rhythm in the US. The pacemaker will be the world's first dual-chamber pacemaker.
• In April 2023: Medtronic Plc in collaboration with DaVita Inc launched a new company "Mozarc-Medical" which will provide innovative & patient-centric technological solutions for kidney health monitoring. The strategic collaboration aimed to transform kidney care procedures globally.
• In May 2022:Max Ventilator launched a non-invasive (NIV) ventilator with built-in oxygen therapy and humidifiers to serve patients suffering from pneumonia and also the product would be used in neonatal care.
• In January 2022: OES Medical introduced a new ventilator at Arab Health. The Gemini-G100 is a new mains-powered ICU ventilator designed to assist hospitals in managing oxygen demand. It reduces hospitals' reliance on oxygen deliveries, especially during peak demand.

Segmentation:

By Product Type

• Implantable Cardioverter-Defibrillators
• Neurostimulation Devices
• Pacemakers
• Respiratory Care Devices
• Surgical Robots

By Diagnostics

• CT Scanners
• MRI Scanners
• Patient Monitoring Devices
• PET/CT Devices
• Ultrasound Devices
• X-ray Devices

By End-User

• Ambulatory Surgical Centers
• Clinics
• Hospital

By Geography

• North America
• USA
• Canada
• Mexico
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. MEDICAL ELECTRONICS MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Implantable Cardioverter-Defibrillators
  • 5.2.1. Market Trends and Opportunities
  • 5.2.2. Growth Prospects
  • 5.2.3. Geographic Lucrativeness Insight
• 5.3. Neurostimulation Devices
  • 5.3.1. Market Trends and Opportunities
  • 5.3.2. Growth Prospects
  • 5.3.3. Geographic Lucrativeness Insight
• 5.4. Pacemakers
  • 5.4.1. Market Trends and Opportunities
  • 5.4.2. Growth Prospects
  • 5.4.3. Geographic Lucrativeness Insight
• 5.5. Respiratory Care Devices
  • 5.5.1. Market Trends and Opportunities
  • 5.5.2. Growth Prospects
  • 5.5.3. Geographic Lucrativeness Insight
• 5.6. Surgical Robots
  • 5.6.1. Market Trends and Opportunities
  • 5.6.2. Growth Prospects
  • 5.6.3. Geographic Lucrativeness Insight

6. MEDICAL ELECTRONICS MARKET BY DIAGNOSTIC

• 6.1. Introduction
• 6.2. CT Scanners
  • 6.2.1. Market Trends and Opportunities
  • 6.2.2. Growth Prospects
  • 6.2.3. Geographic Lucrativeness Insight
• 6.3. MRI Scanners
  • 6.3.1. Market Trends and Opportunities
  • 6.3.2. Growth Prospects
  • 6.3.3. Geographic Lucrativeness Insight
• 6.4. Patient Monitoring Devices
  • 6.4.1. Market Trends and Opportunities
  • 6.4.2. Growth Prospects
  • 6.4.3. Geographic Lucrativeness Insight
• 6.5. PET/CT Devices
  • 6.5.1. Market Trends and Opportunities
  • 6.5.2. Growth Prospects
  • 6.5.3. Geographic Lucrativeness Insight
• 6.6. Ultrasound Devices
  • 6.6.1. Market Trends and Opportunities
  • 6.6.2. Growth Prospects
  • 6.6.3. Geographic Lucrativeness Insight
• 6.7. X-Ray Devices
  • 6.7.1. Market Trends and Opportunities
  • 6.7.2. Growth Prospects
  • 6.7.3. Geographic Lucrativeness Insight

7. MEDICAL ELECTRONICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
  • 7.2.1. Market Trends and Opportunities
  • 7.2.2. Growth Prospects
  • 7.2.3. Geographic Lucrativeness Insight
• 7.3. Clinics
  • 7.3.1. Market Trends and Opportunities
  • 7.3.2. Growth Prospects
  • 7.3.3. Geographic Lucrativeness Insight
• 7.4. Hospitals
  • 7.4.1. Market Trends and Opportunities
  • 7.4.2. Growth Prospects
  • 7.4.3. Geographic Lucrativeness Insight

8. MEDICAL ELECTRONICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Product Type
  • 8.2.2. By Diagnostics
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
      • 8.2.4.1.1. Market Trends and Opportunities
      • 8.2.4.1.2. Growth Prospects
    • 8.2.4.2. Canada
      • 8.2.4.2.1. Market Trends and Opportunities
      • 8.2.4.2.2. Growth Prospects
    • 8.2.4.3. Mexico
      • 8.2.4.3.1. Market Trends and Opportunities
      • 8.2.4.3.2. Growth Prospects
• 8.3. South America
  • 8.3.1. By Product Type
  • 8.3.2. By Diagnostics
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
      • 8.3.4.1.1. Market Trends and Opportunities
      • 8.3.4.1.2. Growth Prospects
    • 8.3.4.2. Argentina
      • 8.3.4.2.1. Market Trends and Opportunities
      • 8.3.4.2.2. Growth Prospects
    • 8.3.4.3. Others
      • 8.3.4.3.1. Market Trends and Opportunities
      • 8.3.4.3.2. Growth Prospects
• 8.4. Europe
  • 8.4.1. By Product Type
  • 8.4.2. By Diagnostics
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
      • 8.4.4.1.1. Market Trends and Opportunities
      • 8.4.4.1.2. Growth Prospects
    • 8.4.4.2. Germany
      • 8.4.4.2.1. Market Trends and Opportunities
      • 8.4.4.2.2. Growth Prospects
    • 8.4.4.3. France
      • 8.4.4.3.1. Market Trends and Opportunities
      • 8.4.4.3.2. Growth Prospects
    • 8.4.4.4. Others
      • 8.4.4.4.1. Market Trends and Opportunities
      • 8.4.4.4.2. Growth Prospects
• 8.5. Middle East and Africa
  • 8.5.1. By Product Type
  • 8.5.2. By Diagnostics
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
      • 8.5.4.1.1. Market Trends and Opportunities
      • 8.5.4.1.2. Growth Prospects
    • 8.5.4.2. UAE
      • 8.5.4.2.1. Market Trends and Opportunities
      • 8.5.4.2.2. Growth Prospects
    • 8.5.4.3. Israel
      • 8.5.4.3.1. Market Trends and Opportunities
      • 8.5.4.3.2. Growth Prospects
    • 8.5.4.4. Others
      • 8.5.4.4.1. Market Trends and Opportunities
      • 8.5.4.4.2. Growth Prospects
• 8.6. Asia Pacific
  • 8.6.1. By Product Type
  • 8.6.2. By Diagnostics
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. Japan
      • 8.6.4.1.1. Market Trends and Opportunities
      • 8.6.4.1.2. Growth Prospects
    • 8.6.4.2. China
      • 8.6.4.2.1. Market Trends and Opportunities
      • 8.6.4.2.2. Growth Prospects
    • 8.6.4.3. India
      • 8.6.4.3.1. Market Trends and Opportunities
      • 8.6.4.3.2. Growth Prospects
    • 8.6.4.4. South Korea
      • 8.6.4.4.1. Market Trends and Opportunities
      • 8.6.4.4.2. Growth Prospects
    • 8.6.4.5. Thailand
      • 8.6.4.5.1. Market Trends and Opportunities
      • 8.6.4.5.2. Growth Prospects
    • 8.6.4.6. Taiwan
      • 8.6.4.6.1. Market Trends and Opportunities
      • 8.6.4.6.2. Growth Prospects
    • 8.6.4.7. Indonesia
      • 8.6.4.7.1. Market Trends and Opportunities
      • 8.6.4.7.2. Growth Prospects
    • 8.6.4.8. Others
      • 8.6.4.8.1. Market Trends and Opportunities
      • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Abbott Laboratories
• 10.2. Allengers Medical
• 10.3. Boston Scientific
• 10.4. Carestream Health
• 10.5. FUJIFILM Corporation
• 10.6. GE Healthcare
• 10.7. Hitachi High Technologies Corporation
• 10.8. Medtronic
• 10.9. Philips Healthcare
• 10.10. Shimadzu Corporation
• 10.11. Siemens Healthcare
• 10.12. Stryker Corporation